Boehringer, Teva Sued Again Over Deal To Delay Generic
Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. were hit Monday with another proposed antitrust class action, this in Minnesota federal court, over an alleged pay-for-delay deal that kept a...To view the full article, register now.
Already a subscriber? Click here to view full article